Sign in

NCT07429773Recruiting

Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP

Source: ClinicalTrials.gov · Last updated 27 Jul 2026

Brief summary (registry, in English)

Chronic pelvic pain (CPP) affects more than one in four women. An immune imbalance in the Th1/Th2 balance has been reported in multiple CPP situations, particularly in patients with endometriosis, but with mixed results. The use of a functional immune test, already validated in previous indications and particularly in infertility, could simulate an immune stimulation similar to that of painful attacks.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
21 Jan 2026
Start date
14 Apr 2026
Primary completion date
30 Apr 2028
Lead sponsor
Centre Hospitalier Universitaire de Nice
NCT number
NCT07429773

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 14 Apr 2026 to the primary completion date, 30 Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Autoimmune disease;
  • History of cancer within the last 5 years or currently undergoing treatment;
  • Current infectious syndrome;

Other

  • Pregnant or breastfeeding women;
  • Person under guardianship or conservatorship.

Who the study is looking for

  • Aged between 18 and 40;
  • Under continuous hormone treatment for at least 6 months;
  • Imaging less than 12 months old: either normal or showing endometriosis and/or adenomyosis lesions, excluding any other abnormalities that could explain the PCOS;
  • Affiliation with the French Social Security system;
  • Signature of informed consent.

Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Nice - Hopital de l Archet 2
Coordinator of this site? Confirm its status
NiceFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.